In the last trading session, 24.33 million shares of the Dogwood Therapeutics Inc (NASDAQ:DWTX) were traded, and its beta was 1.27. Most recently the company’s share price was $3.15, and it changed around $1.28 or 68.45% from the last close, which brings the market valuation of the company to $4.19M. DWTX currently trades at a discount to its 52-week high of $22.25, offering almost -606.35% off that amount. The share price’s 52-week low was $1.62, which indicates that the current value has risen by an impressive 48.57% since then. We note from Dogwood Therapeutics Inc’s average daily trading volume that its 10-day average is 24620.0 shares, with the 3-month average coming to 49.75K.
Dogwood Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended DWTX as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Dogwood Therapeutics Inc is expected to report earnings per share of 0 for the current quarter.
Dogwood Therapeutics Inc (NASDAQ:DWTX) trade information
Instantly DWTX has showed a green trend with a performance of 68.45% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.9900 on recent trading dayincreased the stock’s daily price by 21.05%. The company’s shares are currently up 26.51% year-to-date, but still up 35.78% over the last five days. On the other hand, Dogwood Therapeutics Inc (NASDAQ:DWTX) is 34.62% up in the 30-day period. We can see from the shorts that 13348.0 shares have been sold at a short interest cover period of 0.55 day(s).
Dogwood Therapeutics Inc (DWTX) estimates and forecasts
Dogwood Therapeutics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -49.92 percent over the past six months and at a 8.14% annual growth rate that is well below the industry average of 16.50%.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -2.02%.
DWTX Dividends
Dogwood Therapeutics Inc’s next quarterly earnings report is expected to be released in February.
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 16.71 shares worth $52639.0, making up 1.25% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 5.9 shares worth around $18594.0, which represents about 0.44% of the total shares outstanding.
